•
Jun 30, 2019

McKesson Q1 2020 Earnings Report

Total Revenue
$55.7B
Previous year: $52.6B
+5.9%
EPS
$3.31
Previous year: $2.9
+14.1%
Dividends per share
$0.39
US Pharma Adj. Segment Operating Profit
$600M
Medical-Surgical Adj. Segment Oper. Profit
$159M
Gross Profit
$2.79B
Previous year: $2.78B
+0.3%
Cash and Equivalents
$1.95B
Previous year: $2.2B
-11.5%
Free Cash Flow
-$138M
Previous year: -$1.16B
-88.1%
Total Assets
$61.7B
Previous year: $61.3B
+0.6%

McKesson

McKesson

McKesson Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income